Robotic radical anterior pelvic exenteration: the UCI experience

Area of Science:

• Urology
• Surgical Oncology
• Robotic Surgery

Background:

• Radical anterior pelvic exenteration is a complex procedure for invasive bladder cancer.
• Minimizing morbidity associated with this surgery is a key clinical challenge.
• Robotic technology offers potential benefits in complex oncologic resections.

Purpose of the Study:

• To evaluate the feasibility and outcomes of robotic-assisted radical anterior pelvic exenteration in female patients.
• To assess the safety and efficacy of this minimally invasive approach for urothelial carcinoma.

Main Methods:

• Retrospective review of 12 female patients who underwent robotic-assisted anterior pelvic exenteration, pelvic lymphadenectomy, and urinary diversion (2004-2008).
• Data collected included operative times, blood loss, length of stay, pathological findings, and short-term outcomes.
• Urinary diversions included ileal conduit, orthotopic neobladder, and Indiana pouch.

Main Results:

• Median operating time was 6.4 hours, with median blood loss of 275 ml and median hospital stay of 8 days.
• Pathological stages ranged from T2N0 to T4N0, with one patient having positive surgical margins.
• Short-term follow-up revealed complications including ureteroenteric stricture, vault prolapse, and metastatic disease in some patients.

Conclusions:

• Robotic-assisted anterior pelvic exenteration is a viable surgical option for selected female patients with invasive bladder cancer.
• The technique demonstrates acceptable operative, pathological, and short-term clinical outcomes.
• This approach appears to achieve clinical and oncologic goals in the surgical management of bladder cancer.